| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | GYRE | Common Stock | Sale | $20,780 | -2,000 | -0.07% | $10.39 | 2,913,138 | 14 Jan 2025 | By Spouse | F1, F2 |
| transaction | GYRE | Common Stock | Sale | $21,700 | -2,000 | -0.07% | $10.85 | 2,911,138 | 15 Jan 2025 | By Spouse | F1, F3 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on September 13, 2024. |
| F2 | The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $10.13 to $10.60. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. |
| F3 | The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $10.74 to $11.08. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. |